Gilead Sciences Inc
GILDHealth careStock · Data from SEC EDGAR 13F · Held by 16 of 87 tracked investors
Gilead Sciences Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation83
- Growth52
- Profitability49
- Quality54
- Debt78
- Stability91
- It pays a 2.1% dividend, which takes 43% of earnings.
Chart GILD
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
16JS Jim Simons Renaissance Technologies | 0.39% |
GI Generali Investments CEE Generali Investments CEE | 0.32% |
Ns Norský státní fond Norges Bank | 0.28% |
Čn Česká národní banka Česká národní banka | 0.28% |
JR John Rogers Ariel Investments | 0.25% |
Šn Švýcarská národní banka Swiss National Bank | 0.23% |
SC Steven Cohen Point72 Asset Management | 0.2% |
RD Ray Dalio Bridgewater Associates | 0.15% |
JG Joel Greenblatt Gotham Asset Management | 0.11% |
IE Israel Englander Millennium Management | 0.07% |
KG Ken Griffin Citadel Advisors | 0.05% |
CA Cliff Asness AQR Capital Management | 0.03% |
PT Paul Tudor Jones Tudor Investment Corp | 0.01% |
JY Jeff Yass Susquehanna International Group | 0.01% |
RB Ron Baron Baron Capital | 0% |
KF Ken Fisher Fisher Investments | 0% |
Frequently asked questions
How much is Gilead Sciences Inc (GILD) stock?
Gilead Sciences Inc shares trade at $156.04, -0.73% over the last trading day. The price is delayed.
What is the market cap of Gilead Sciences Inc?
The market cap of Gilead Sciences Inc is about $193B.
Does Gilead Sciences Inc pay a dividend?
The dividend yield of Gilead Sciences Inc is 2.09% a year. The yield can change with the company's decisions.
How has Gilead Sciences Inc stock performed over the last year?
The Gilead Sciences Inc share price changed by +29.02% over 12 months and by +140.51% over 5 years.
Which big investors hold Gilead Sciences Inc?
According to the latest 13F filings, 16 of 87 tracked investors hold Gilead Sciences Inc, for example Jim Simons, Generali Investments CEE, Norský státní fond.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.